Portfolio - Systems - Applications & Solutions - Experiences Community Education Stories Downloads Contact Us Upgrade your mammography system to 3D breast tomosynthesis for more clarity and more confidence at low dose SenoClaireTM GE Mammography system Download Contact us SenoClaireTM mammography system for 3D breast tomosynthesis, powered by ASiRDBT, provides superior diagnostic accuracy at the same low dose as a 2D FFDM exam1, giving you more clinical confidence for breast cancer detection while delivering the same amount of dose as a digital mammography acquisition of the same view. 1. GE screening protocol consists of 3D CC/MLO + V-Preview CC/MLO, V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020/S001 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=P130020S001, Data on file. More clarity for diagnostic imaging Breast exam images of outstanding detail for superior diagnostic accuracy1 More confidence for breast cancer detection and diagnosis Care with confidence. Connect with compatibility. Low dose 3D breast tomosynthesis Half the dose with one single compression. Increasing clinical confidence for mammography with 3D breast tomosynthesis 2D ML0 3D ML0 V-preview GE 3D Mammography Community Our community is aimed at improving the quality of content shared and overall patient experience. Click here to find important resources and links. Read more Education Gain the knowledge you need to operate your equipment effectively, optimize image quality and care for your patients. Read more Stories Stay connected with us for our latest mammography developments – including provider and patient stories, events and more. Read more See more clearly. Screen more effectively. Characterize more specifically. More clarity More info More clarity See more clearly SenoClaireTM improves the specificity of mammography by improving lesion margin visibility. Images of outstanding detail Our technology provides images of outstanding detail and superior diagnostic accuracy, which helps clinicians provide exceptional care and puts patients’ minds at ease. Characterize more specifically SenoClaireTM enables better characterization of malignant and benign findings by providing a 3D MLO view that has superior detection for architectural distortions and masses1 compared with 2D FFDM. Clinical results have shown that the recall rate after a 3D MLO examination is lower than the recall rate after a 2D FFDM exam.1 1. GE screening protocol consists of 3D CC/MLO + V-Preview CC/MLO, V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020/S001 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=P130020S001, Data on file. Powered by SenoClaire technology: The SenoClaireTM detector delivers high DQE at low dose for visualizing microcalcifications without binning, a process that regroups pixels for faster readout speeds and improved signal-to-noise ratios, but with reduced image quality. Step-and-shoot tube motion preserves microcalcification sharpness and avoids image blur, since the tube makes a complete stop for each of the nine exposures. This provides higher peak contrast for microcalcifications than traditional continuous tube motion. An anti-scatter solution designed for tomosynthesis, the SenoClaireTM grid in 3D reduces scattered radiation and improves detectability in 3D for breasts of above-average thickness, while preserving dose and performance. SenoClaireTM uses ASiRDBT, an iterative reconstruction algorithm that yields FFDM-like images and positively impacts microcalcification conspicuity versus the traditional Filtered Back Projection (FBP) algorithm. Close Care with confidence. Connect with compatibility. More confidence More info More confidence Care with confidence Because GE builds the Senographe with upgradability in mind, you can easily expand the system as your needs and capabilities grow. SenoClaireTM 3D breast tomosynthesis, stereotaxy, or SenoBright* contrast enhanced spectral mammography are fully compatible with any Senographe Essential and Senographe Care. It’s an excellent balance of precision and performance, so you can be confident in your investment. investment. Connect SenoClaireTM images are compatible with major PACS providers (with local variability), allowing integration into your environment and helping you make optimal use of your investment. With the IDI MammoWorkstation, radiologists can smoothly navigate through the DBT dataset using dedicated 2D/3D hanging protocols and specific ergonomic features: Straightforward visual identification of all series of tomosynthesis planes and slabs Dedicated tools to review tomosynthesis data sets: cine loop, bookmarks, breast localizer, breast height ruler V-Preview reconstructed images from tomosynthesis Close Same low dose as a 2D exam, the lowest patient dose of all FDA approved DBT systems.1 Low dose More info Low dose It’s a requirement of dose performance that patient X-ray dose be kept as low as reasonably acceptable. SenoClaireTM technology provides images of outstanding detail and superior diagnostic accuracy at the same low dose as a 2D exam, the lowest patient dose of all FDA approved DBT systems.1 gehealthcare.com/mammography 1. GE screening protocol consists of 3D CC/MLO + V-Preview CC/MLO, V-Preview is the 2D synthesized image generated by GE Seno Iris mammography software from GE DBT images. FDA PMA P130020/S001 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm?id=P130020S001, Data on file. Average glandular dose in digital mammography and digital breast tomosynthesis: comparison of phantom and patient data. Bouwman, R. W. and al., et. 2015, Physics in Medicine & Biology, pp. 7893-7907. Powered by SenoClaire technology: SenoClaire's ASiRDBT iterative reconstruction algorithm delivers FFDM-like images and positively impacts microcalcification conspicuity versus the traditional Filtered Back Projection (FBP) algorithm. SenoClaire's 3D MLO sequence requires only nine exposures with an even distribution of the dose. The SenoClaireTM grid in 3D reduces scattered radiation and improves detectability in 3D for breasts of above-average thickness, while preserving dose and performance. The dual-track X-ray tube (Mo/Rh) delivers optimal X-ray spectra to penetrate the breast based on breast density and compressed breast thickness. Automatic Optimization of Parameters (AOP) helps you identify the densest breast regions and automatically selects the appropriate anode, filter, kV and mAs to ensure repeatable image quality at optimized radiation dose. Close Top
